IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells

Hepatology

Volumn 60, Issue 6, 2014, Pages 1879-1890

  Preisser, Laurence ^a,b,c   Miot, Charline ^a,b,c   Le Guillou Guillemette, Hélène ^a,d   Beaumont, Elodie ^b,e   Foucher, Etienne D ^a,b,c   Garo, Erwan ^a,b,c   Blanchard, Simon ^a,b,c,d   Frémaux, Isabelle ^a,b,c   Croué, Anne ^d,f   Fouchard, Isabelle ^d   Lunel Fabiani, Françoise ^a,d   Boursier, Jérôme ^a,d   Roingeard, Philippe ^b,e   Calès, Paul ^a,d   Delneste, Yves ^a,b,c,d   Jeannin, Pascale ^a,b,c,d  

^a UNIVERSITÉ D'ANGERS   (France)

^b INSERM   (France)

^c Groupe Cytokines et Récepteurs   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE TOURS   (France)

^f UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN DERIVATIVE; INTERLEUKIN-13, HUMAN; INTERLEUKIN-34, HUMAN; INTERSTITIAL COLLAGENASE; MMP1 PROTEIN, HUMAN;

ADULT; AGED; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL LINE; COMPLICATION; FEMALE; HEPATITIS C; HUMAN; IMMUNOLOGY; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; SECRETION (PROCESS); STELLATE CELL;

ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE; COLLAGEN TYPE I; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKINS; KILLER CELLS, NATURAL; LIVER CIRRHOSIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED;

EID: 84911904020     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27328     Document Type: Article

References (41)

1. Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 2013;305:C789-C799.
2. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011;6:425-456.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
4. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007;131:1728-1734.
5. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.
6. Liu Y, Munker S, Mullenbach R, Weng HL. IL-13 Signaling in liver fibrogenesis. Front Immunol 2012;3:116.
7. Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, Godoy P, et al. The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 2009;50:230-243.
8. Tacke F. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo. Fibrogenesis Tissue Repair 2012;5(Suppl. 1):S27.
9. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787-795.
10. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010;30:245-257.
11. Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology 2014;59:2034-242.
12. Ma X, Lin WY, Chen Y, Stawicki S, Mukhyala K, Wu Y, et al. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 2012;20:676-687.
13. Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008;320:807-811.
14. Foucher ED, Blanchard S, Preisser L, Garo E, Ifrah N, Guardiola P, et al. IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNgamma. PLoS One 2013;8:e56045.
15. Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007;110:4319-4330.
16. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.
17. Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest 2013;123:4121-4130.
18. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-293.
19. Duluc D, Tan F, Scotet M, Blanchard S, Fremaux I, Garo E, et al. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta. Eur J Immunol 2009;39:2877-2884.
20. Ferraris P, Beaumont E, Uzbekov R, Brand D, Gaillard J, Blanchard E, Roingeard P. Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Cell Mol Life Sci 2013;70:1297-1306.
21. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
22. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 2009;119:1858-1870.
23. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573.
24. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-686.
25. Gao B, Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013;1832:1061-1069.
26. Nagashima H, Nakamura K, Goto T. Rubratoxin B induced the secretion of hepatic injury-related colony stimulating factors in human hepatoma cells. Toxicol Lett 2003;145:153-159.
27. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008;26:2707-2716.
28. Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 2013;58:1461-1473.
29. Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012;55:343-353.
30. Uchinami H, Seki E, Brenner DA, D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006;44:420-429.
31. Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi SK, et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 2003;124:445-458.
32. Sugimoto R, Enjoji M, Nakamuta M, Ohta S, Kohjima M, Fukushima M, et al. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int 2005;25:420-428.
33. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014;14:181-194.
34. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005;128:138-146.
35. + monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009;50:261-274.
36. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012;61:416-426.
37. Yamamoto T, Kaizu C, Kawasaki T, Hasegawa G, Umezu H, Ohashi R, et al. Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion. Cell Tissue Res 2008;332:245-256.
38. Radi ZA, Koza-Taylor PH, Bell RR, Obert LA, Runnels HA, Beebe JS, et al. Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am J Pathol 2011;179:240-247.
39. Wiktor-Jedrzejczak W, Urbanowska E, Szperl M. Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient op/op mouse. Endocrinology 1994;134:1932-1935.
40. Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, et al. Serum levels of macrophage colony stimulating factor (M-CSF) in liver disease. J Hepatol 1994;21:527-535.
41. Baran CP, Opalek JM, McMaken S, Newland CA, O'Brien JM, Jr., Hunter MG, et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:78-89.